BCL2 mRNA or protein abundance is superior to gene rearrangement status in predicting clinical outcomes in patients with diffuse large B-cell lymphoma
Li, Y., Tyryshkin, K., Good, D., Farmer, P., Scott, D.W., Crocker, S., Baetz, T., LeBrun, D.Volume:
35
Language:
english
Journal:
Hematological Oncology
DOI:
10.1002/hon.2439_17
Date:
June, 2017
File:
PDF, 327 KB
english, 2017